WeChat-based MHealth Intention and Preferences Among People Living with Schizophrenia
Overview
Environmental Health
General Medicine
Authors
Affiliations
Background: The past few decades have seen a rapid expansion of mHealth programs among people with serious mental illness, yet mHealth for schizophrenia is in a much earlier stage of development. This study examined the intention of WeChat-based mHealth programs among people living with schizophrenia (PLS) and evaluated correlates of the intention.
Methods: A total of 400 PLS aged 18-77 completed a cross-sectional survey by face-to-face interviews. The survey included a general question asking about participants' willingness to attend WeChat-based mHealth programs, followed by preferences of three specific WeChat-based programs: psychoeducation, peer support, and professional support. PLS symptoms, functioning and disability were measured using the 18-item Brief Psychiatric Rating Scale (BPRS-18), the Global Assessment of Functioning (GAF), and the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), respectively. A multivariate logistic regression was used to determine correlates of program participation intention.
Results: Over forty percent (43%, = 172) of participants were willing to participate in WeChat-based mHealth programs, among whom preferences for each specific program were shown in descending order: psychoeducation (68.60%), professional support (60.47%), and peer support (52.33%). A multivariate analysis revealed that younger age (OR: 0.13-0.20, 95% CI [0.05-0.43]), higher education (OR: 3.48-6.84, 95% CI [1.69-18.21]), and lower disability (OR: 0.97, 95% CI [0.94-0.99]) were all independently associated with WeChat-based mHealth program participation intention.
Conclusion: The findings provide guidance for further development of WeChat-based mHealth programs among PLS in China, and targeted at those who are younger, well-educated and with lower disability.
Acceptability of Tele-mental Health Services Among Users: A Systematic Review and Meta-analysis.
Abuyadek R, Hammouda E, Elrewany E, Elmalawany D, Ashmawy R, Zeina S BMC Public Health. 2024; 24(1):1143.
PMID: 38658881 PMC: 11040906. DOI: 10.1186/s12889-024-18436-7.
Li M, Chen Y, Hu X, Wang S BMC Psychiatry. 2023; 23(1):361.
PMID: 37226168 PMC: 10210282. DOI: 10.1186/s12888-023-04885-8.
Wang Y, Li C, Zhang J, Yang M, Zhu G, Liu Y Malar J. 2022; 21(1):381.
PMID: 36514171 PMC: 9745723. DOI: 10.1186/s12936-022-04404-2.
Accessibility and availability of smartphone apps for schizophrenia.
Kwon S, Firth J, Joshi D, Torous J Schizophrenia (Heidelb). 2022; 8(1):98.
PMID: 36385116 PMC: 9668219. DOI: 10.1038/s41537-022-00313-0.
Ma Z, Huang S, Wu X, Huang Y, Chan S, Lin Y J Med Internet Res. 2022; 24(3):e35768.
PMID: 35262503 PMC: 8943552. DOI: 10.2196/35768.